In contrast, RA patients in the reduced irisin group exhibited significantly lower skeletal muscle mass at all sites and a lower SMI compared with those in the normal irisin group (all P < 0.05) (Table 2). This evidence concerns the gene FNDC5 and rheumatoid arthritis.